Concepedia

David Hosking

DH

Statistics

Publications

37

Citations

4.7K

H-Index

29

Active since

1978

Affiliations

Nottingham City Hospital(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of Auckland

University of Nottingham

Center for Clinical & Basic Research

David Hosking is an author at Nottingham City Hospital specializing in medicine, bone metabolism, and bone metabolism disorders.

Publications per year

1978–2014

37

Publications

37

Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women

Henry G. Bone, David Hosking, Jean‐Pierre Devogelaer et al. · New England Journal of Medicine · 2004 · 1.4K citations · Full text

, , +13

Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age

David Hosking, Clair E.D. Chilvers, Claus Christiansen et al. · New England Journal of Medicine · 1998 · 487 citations · Full text

, , +17

Comparison of a Single Infusion of Zoledronic Acid with Risedronate for Paget's Disease

Ian R. Reid, Paul D. Miller, Kenneth W. Lyles et al. · New England Journal of Medicine · 2005 · 434 citations · Full text

, , +3

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect

John A. Eisman, Henry G. Bone, David Hosking et al. · Journal of Bone and Mineral Research · 2010 · 246 citations · Full text

, , +16

Prevention of Bone Loss With Alendronate in Postmenopausal Women Under 60 Years of Age

David Hosking, Clair Chilvers, Claus Christiansen et al. · Obstetrical & Gynecological Survey · 1998 · 211 citations

, , +17

1–5 of 37